Search research articles
Contact Us
Filters
Showing results (121-130 of 129) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 129 results.
Blood Advances
|
June 5, 2023
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
Pierre Fenaux, Marco Gobbi, Patricia L Kropf, et al.
Leukemia & Lymphoma
|
April 10, 2008
Prognostic implications of the immunophenotype in biphenotypic acute leukemia
Je-Hwan Lee, Yoo Hong Min, Chul Won Chung, et al.
Journal of Hematology & Oncology
|
August 15, 2012
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
Yu Ri Kim, Jin Seok Kim, Yoo Hong Min, et al.
American Journal of Hematology
|
October 19, 2012
Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients
Inho Kim, Youngil Koh, Sung-Soo Yoon, et al.
Japanese Journal of Clinical Oncology
|
February 27, 2010
Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment
Ho-Jin Shin, Hyeoung-Joon Kim, Sang Kyun Sohn, et al.
Journal of Korean Medical Science
|
January 17, 2014
Success rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in Korea
Soo-Jeong Kim, June-Won Cheong, Yoo Hong Min, et al.
Annals of Hematology
|
May 28, 2016
Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide study
Ja Min Byun, Young Jin Kim, Hwi-Joong Yoon, et al.
Leukemia & Lymphoma
|
April 6, 2011
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia
Sang Kyun Sohn, Suk Joong Oh, Byung Soo Kim, et al.
International Journal of Hematology
|
July 6, 2014
Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients
Soo-Jeong Kim, June-Won Cheong, Dae-Young Kim, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 129) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 129 results.
Blood Advances
|
June 5, 2023
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
Pierre Fenaux, Marco Gobbi, Patricia L Kropf, et al.
Leukemia & Lymphoma
|
April 10, 2008
Prognostic implications of the immunophenotype in biphenotypic acute leukemia
Je-Hwan Lee, Yoo Hong Min, Chul Won Chung, et al.
Journal of Hematology & Oncology
|
August 15, 2012
Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
Yu Ri Kim, Jin Seok Kim, Yoo Hong Min, et al.
American Journal of Hematology
|
October 19, 2012
Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients
Inho Kim, Youngil Koh, Sung-Soo Yoon, et al.
Japanese Journal of Clinical Oncology
|
February 27, 2010
Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment
Ho-Jin Shin, Hyeoung-Joon Kim, Sang Kyun Sohn, et al.
Journal of Korean Medical Science
|
January 17, 2014
Success rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in Korea
Soo-Jeong Kim, June-Won Cheong, Yoo Hong Min, et al.
Annals of Hematology
|
May 28, 2016
Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide study
Ja Min Byun, Young Jin Kim, Hwi-Joong Yoon, et al.
Leukemia & Lymphoma
|
April 6, 2011
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia
Sang Kyun Sohn, Suk Joong Oh, Byung Soo Kim, et al.
International Journal of Hematology
|
July 6, 2014
Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients
Soo-Jeong Kim, June-Won Cheong, Dae-Young Kim, et al.
Page
of 13